Thiemann F T, Moore K A, Smogorzewska E M, Lemischka I R, Crooks G M
Division of Research Immunology and Bone Marrow Transplantation, Childrens Hospital Los Angeles, California 90027, USA.
Exp Hematol. 1998 Jul;26(7):612-9.
A stromal cell line derived from murine fetal liver (AFT024) has been demonstrated to maintain long-term repopulating murine stem cells for up to 7 weeks in vitro. We evaluated the ability of AFT024 to maintain the immunophenotype and function of primitive human progenitors in vitro by comparing the cocultivation of CD34+CD38 cells on AFT024 with that on primary human stroma (HS). We have previously reported that within the CD34+CD38- population of bone marrow and cord blood, a highly primitive progenitor subpopulation can be identified functionally by its ability to generate colony forming unit-cells (CFU-Cs) in extended long-term culture (ELTC), that is, beyond 60 days of stromal cocultivation. Cocultivation of bone marrow and cord blood CD34+CD38-cells on AFT024 produced significantly greater cell expansion (p=0.0002) and CFU-C output (p=0.0007) during the ELTC period compared with culturing on HS. CFU-C production continued up to 9 weeks longer on AFT024 stroma. After 3 to 4 weeks of bulk culture on either AFT024 or HS, cells were replated in a limiting dilution to measure the number of cobblestone area-forming cells (CAFCs) maintained on each stroma. AFT024 maintained significantly more CAFCs than did HS (n=3, p=0.002). Fluorescence-activated cell sorter analysis of AFT024 and HS cocultures showed that both the frequency (p=0.018) and absolute number (p=0.027) of CD34+CD38- cells were significantly higher in cultures on AFT024 than in those on HS (n=9). The effects of AFT024 on preservation of primitive progenitors were not seen in transwell (noncontact) cultures. Thus, AFT024 acts by direct contact to maintain the phenotype and function of the most primitive and quiescent human progenitors currently identifiable by in vitro assays.
源自小鼠胚胎肝脏的基质细胞系(AFT024)已被证明能够在体外长达7周的时间内维持长期重建造血的小鼠干细胞。我们通过比较CD34+CD38细胞在AFT024上与在原代人基质(HS)上的共培养情况,评估了AFT024在体外维持原始人类祖细胞免疫表型和功能的能力。我们之前报道过,在骨髓和脐血的CD34+CD38-群体中,一个高度原始的祖细胞亚群可以通过其在延长的长期培养(ELTC)中,即基质共培养超过60天时产生集落形成单位细胞(CFU-Cs)的能力,从功能上得以鉴定。与在HS上培养相比,骨髓和脐血CD34+CD38-细胞在AFT024上共培养在ELTC期间产生了显著更大的细胞扩增(p = 0.0002)和CFU-C产量(p = 0.0007)。在AFT024基质上CFU-C的产生持续时间比在HS上长9周。在AFT024或HS上进行3至4周的批量培养后,将细胞以有限稀释度重新接种,以测量在每种基质上维持的鹅卵石区域形成细胞(CAFCs)的数量。AFT024维持的CAFCs明显多于HS(n = 3,p = 0.002)。对AFT024和HS共培养物进行荧光激活细胞分选分析表明,在AFT024上培养的CD34+CD38-细胞的频率(p = 0.018)和绝对数量(p = 0.027)均显著高于在HS上培养的(n = 9)。在transwell(非接触)培养中未观察到AFT024对原始祖细胞保存的影响。因此,AFT024通过直接接触来维持目前通过体外试验可鉴定的最原始和静止的人类祖细胞的表型和功能。